IL-38 augmentation strategy could be effective also for other inflammatory skin diseases with an abundant neutrophil infiltrate such as GPP, PPP, hidradenitis suppurativa, Sweet syndrome and pyoderma gangrenosum, in which a reduced expression of IL-38 has been observed. Here, IL1F10 is linked to sweet syndrome.